157 related articles for article (PubMed ID: 28283091)
1. CYP1A1 I462V polymorphism is associated with reduced genotoxicity in yeast despite positive association with increased cancer risk.
Freedland J; Cera C; Fasullo M
Mutat Res Genet Toxicol Environ Mutagen; 2017 Mar; 815():35-43. PubMed ID: 28283091
[TBL] [Abstract][Full Text] [Related]
2. CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae.
Kannan A; Perpetua N; Dolan M; Fasullo M
Mutat Res Genet Toxicol Environ Mutagen; 2022; 874-875():503440. PubMed ID: 35151423
[TBL] [Abstract][Full Text] [Related]
3. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
Fasullo M; Smith A; Egner P; Cera C
Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
[TBL] [Abstract][Full Text] [Related]
4. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants.
Schwarz D; Kisselev P; Cascorbi I; Schunck WH; Roots I
Carcinogenesis; 2001 Mar; 22(3):453-9. PubMed ID: 11238186
[TBL] [Abstract][Full Text] [Related]
5. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.
Fasullo M; Freedland J; St John N; Cera C; Egner P; Hartog M; Ding X
Environ Mol Mutagen; 2017 May; 58(4):217-227. PubMed ID: 28436563
[TBL] [Abstract][Full Text] [Related]
6. Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity.
Schwarz D; Kisselev P; Schunck WH; Chernogolov A; Boidol W; Cascorbi I; Roots I
Pharmacogenetics; 2000 Aug; 10(6):519-30. PubMed ID: 10975606
[TBL] [Abstract][Full Text] [Related]
7. Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.
Lewis BC; Korprasertthaworn P; Miners JO
Pharmacogenet Genomics; 2016 Oct; 26(10):453-61. PubMed ID: 27428168
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
Sengstag C; Weibel B; Fasullo M
Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
[TBL] [Abstract][Full Text] [Related]
9. Human CYP1A1-activated aneugenicity of aflatoxin B1 in mammalian cells and its combined effect with benzo(a)pyrene.
Wang H; Fan Q; Liang Q; Wu Y; Ye Z; Wu H; Sun Q; Tang H; Liu Y; Liu Q; Chen Y
Chem Biol Interact; 2024 Apr; 392():110923. PubMed ID: 38382706
[TBL] [Abstract][Full Text] [Related]
10. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
11. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility.
Persson I; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 1997 Feb; 231(1):227-30. PubMed ID: 9070254
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 gene polymorphisms: modulator of genetic damage in coal-tar workers.
Giri SK; Yadav A; Kumar A; Dev K; Gulati S; Gupta R; Aggarwal N; Gautam SK
Asian Pac J Cancer Prev; 2012; 13(7):3409-16. PubMed ID: 22994769
[TBL] [Abstract][Full Text] [Related]
13. Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone.
Zheng Q; Sha X; Liu J; Heath E; Lorusso P; Li J
Mol Cancer Ther; 2010 Oct; 9(10):2803-13. PubMed ID: 20713530
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China.
London SJ; Yuan JM; Coetzee GA; Gao YT; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):987-91. PubMed ID: 11008920
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
[TBL] [Abstract][Full Text] [Related]
16. Benzo[
Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer.
Ezzeldin N; El-Lebedy D; Darwish A; El-Bastawisy A; Hassan M; Abd El-Aziz S; Abdel-Hamid M; Saad-Hussein A
Genes Environ; 2017; 39():7. PubMed ID: 28074113
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor.
Anttila S; Tuominen P; Hirvonen A; Nurminen M; Karjalainen A; Hankinson O; Elovaara E
Pharmacogenetics; 2001 Aug; 11(6):501-9. PubMed ID: 11505220
[TBL] [Abstract][Full Text] [Related]
20. An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA-reactive metabolites.
Kommaddi RP; Turman CM; Moorthy B; Wang L; Strobel HW; Ravindranath V
J Neurochem; 2007 Aug; 102(3):867-77. PubMed ID: 17630984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
